Clinical phenotypes and prognoses of microscopic polyangiitis based on kidney biopsies

Abstract

Abstract Background To classify the different clinical phenotypes and compare the distinct prognoses of microscopic polyangiitis (MPA). Methods A retrospective analysis of 436 patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) from 2015 to 2022 was conducted in our center, of which 90 patients were diagnosed with MPA and underwent renal biopsy. Results Among the 90 MPA patients, 63% were female, and the median age at onset was 63 years (25th–75th percentile: 58–68). The median follow-up time was 26 months (25th–75th percentile: 10–53). We identified four subtypes: renal impairment type (cluster 1, 39%), pure type (cluster 2, 22%), systemic inflammation type (cluster 3, 26%), and rapid progress type (cluster 4, 13%). Cluster 1, characterized by renal dysfunction at onset (80%), demonstrated poor prognoses with only 26% achieved complete remission (CR), 11% dying, and 19% developing renal failure. In contrast, patients in cluster 2, exclusively female, most had only kidney involvement showed the best prognoses with 55% achieving CR and none experiencing death or renal failure within 10 years. Cluster 3 mostly consisted of males; high fever and C-reactive protein levels were the primary characteristics. These cases exhibited moderate prognoses with 53% achieving CR, 9% dying, and 4% developing renal failure. Finally, patients in cluster 4, which was characterized by rapidly progressive glomerulonephritis, had the worst prognoses, with none achieving CR, 8% dying, and 75% developing renal failure despite aggressive treatment. Conclusions MPA is classified into four subtypes with distinct clinical manifestations and prognoses.

Keywords

• Microscopic polyangiitis
• Kidney biopsy
• Clinical phenotypes
• Prognosis